Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial
about
Altered dietary salt intake for people with chronic kidney diseaseEmerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatologyMeasurement of renal function in patients with chronic kidney diseaseBiomarkers in nephrology: Core Curriculum 2013Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysisRenal recoverySYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trialUrinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men.The use of targeted biomarkers for chronic kidney disease.Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathyKidney injury molecule-1 expression is closely associated with renal allograft damage.Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.Human apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunctionAssessment and diagnosis of renal dysfunction in the ICU.Early Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome: Preliminary Report.Effects of 5/6 nephrectomy on renal function and blood pressure in miceTubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.Follow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI).Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).Aldosterone induces NRK-52E cell apoptosis in acute kidney injury via rno-miR-203 hypermethylation and Kim-1 upregulation.Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis.Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers.Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over timeKidney injury molecule-1 and microalbuminuria levels in Zambian population: biomarkers of kidney injuryl-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Acute kidney injury in childhood: should we be worried about progression to CKD?Current and novel renal biomarkers in heart failure.Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges.Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells?Kidney injury molecule-1 as an early detection tool for acute kidney injury and other kidney diseases.Predicting acute kidney injury: current status and future challenges.Kidney injury molecule-1 in kidney disease.Biomarkers for the early detection of acute kidney injury.Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studiesKidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia.Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease
P2860
Q24188104-CD013A50-D492-4035-8A63-51529FFA6DC6Q26829452-0C47A12C-D09B-41D9-8F9C-8D8DFFCCC03DQ26853698-C794FF36-75DB-40B0-A5F9-34FE489CE69AQ26861451-FC5C99EE-DEAB-4F5F-8A44-586D4AECC29EQ28729196-70FBB9A9-2628-4403-AD0D-6FB831287624Q33750273-CF0CDFD6-C466-4B72-88EF-6A627F67CE2EQ33890104-57029D34-6435-469F-AA79-F354154FD230Q34008962-DB085E3D-A3D2-4663-A950-8D668C49D3BDQ34346928-3287093B-7680-4F35-8921-83474C5CDF7BQ34642815-64619203-BDCC-4530-B1AF-861693412775Q34670737-7CE3889B-1B6F-449E-A26F-C136076B8F11Q34803229-5D8BD9B6-4334-4A57-A47E-FE7ECEE4338CQ35099941-F2C4ABA1-DF71-4D30-93AE-1982C1BBD5A5Q35985704-6DBC8D5F-6A5F-4B10-8DD7-DA660EB4DF2DQ35992007-94E8FEAA-63DD-4DF0-A8B8-34923263FB07Q36009080-18436677-A4FF-4E9D-8393-CF9196CA6ACDQ36207035-4226B4EA-B3A1-4744-AC21-F296E9233A74Q36304054-066313DB-7150-441E-9885-386DF1F91823Q36344899-EF3BAE6C-8CC2-4CF3-B704-83E3536820BBQ36432903-13B54255-ABD8-47D1-8539-07048CFD5617Q36950546-CC7608ED-8728-405C-B15F-53E3B49A1A54Q37106622-DB0DF0DC-39BE-4BC2-8575-169D0CE068DDQ37128891-A5EEA4EE-50A2-42CA-856F-2470C87641DFQ37142447-886F1514-F92A-4F3C-B347-45791EBF4CEAQ37190253-94A433AD-C8F1-4D55-A2AE-1B3FCD229ADCQ37235087-0A847726-EA64-48DB-B285-E1D425BAD575Q37412089-DD3F0603-3CA8-4156-B896-76AA0F2290D1Q37799323-2964B00C-8281-445F-8521-1F487B03F98AQ37878418-97FA7813-72CA-4596-BFA4-4E52CD3E8E1AQ37900203-A55673B5-B9C4-4E79-B5FD-8772B257950EQ38029606-862AC978-2FE8-4CEA-A20F-E397BFD61A2FQ38054004-04EFBE86-6A1B-4C74-8983-4D13114A94D5Q38088374-B49EA898-BB19-41B7-A76B-6E1D71FABE50Q38669818-5C4473C4-C7FE-47F5-835C-53BAA761C0B2Q38985062-FD2F6B7B-E418-4B16-8B9D-AFB2FD6E7DE7Q39791593-51993AAE-7535-4E7C-84E0-2145501051DBQ40715066-A1331CDF-7134-40F6-A3B8-A4525F1A3BEBQ42155627-5403B358-F53D-4FF0-91B2-938DFAF58EA1Q42275787-C65574FA-3049-4DA9-A6D3-F759693A8A1CQ42546522-60F2D586-B95E-46E8-9CD2-C12FB65B31F2
P2860
Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Effect of renin-angiotensin-al ...... a randomized controlled trial
@ast
Effect of renin-angiotensin-al ...... a randomized controlled trial
@en
type
label
Effect of renin-angiotensin-al ...... a randomized controlled trial
@ast
Effect of renin-angiotensin-al ...... a randomized controlled trial
@en
prefLabel
Effect of renin-angiotensin-al ...... a randomized controlled trial
@ast
Effect of renin-angiotensin-al ...... a randomized controlled trial
@en
P2093
P2860
P1476
Effect of renin-angiotensin-al ...... a randomized controlled trial
@en
P2093
Femke Waanders
Gerjan Navis
Harry van Goor
Inge Hamming
Joseph V Bonventre
Kevin Damman
Vishal S Vaidya
P2860
P356
10.1053/J.AJKD.2008.07.021
P577
2008-09-27T00:00:00Z